NanoString Technologies, Inc. (NASDAQ:NSTG) updated its FY17 earnings guidance on Tuesday. The company provided EPS guidance of ($2.20)-($2.03) for the period, compared to the Thomson Reuters consensus EPS estimate of ($2.33). The company issued revenue guidance of $114-$118 million, compared to the consensus revenue estimate of $108.47 million.

A number of research firms recently issued reports on NSTG. Zacks Investment Research raised NanoString Technologies from a hold rating to a buy rating and set a $19.00 target price on the stock in a research report on Wednesday, July 5th. ValuEngine raised NanoString Technologies from a sell rating to a hold rating in a research report on Friday, June 2nd. Cowen and Company reaffirmed a buy rating on shares of NanoString Technologies in a research report on Friday, July 14th. BidaskClub cut NanoString Technologies from a sell rating to a strong sell rating in a report on Friday, July 28th. Finally, Morgan Stanley cut NanoString Technologies from an overweight rating to an equal weight rating and reduced their price target for the stock from $23.00 to $20.00 in a report on Thursday, April 20th. Two research analysts have rated the stock with a sell rating, two have given a hold rating and one has given a buy rating to the stock. NanoString Technologies has an average rating of Hold and a consensus target price of $19.50.

NanoString Technologies, Inc. (NASDAQ:NSTG) traded up 0.20% during trading on Tuesday, reaching $15.30. The company had a trading volume of 215,012 shares. The company has a 50-day moving average price of $15.94 and a 200 day moving average price of $17.81. The company’s market capitalization is $331.86 million. NanoString Technologies, Inc. has a one year low of $13.19 and a one year high of $23.45.

WARNING: This report was posted by American Banking News and is the property of of American Banking News. If you are viewing this report on another website, it was stolen and republished in violation of international copyright and trademark legislation. The correct version of this report can be accessed at

NanoString Technologies Company Profile

NanoString Technologies, Inc develops, manufactures and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Company is engaged in the development, manufacture and commercialization of instruments, consumables and services for profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample.

Receive News & Ratings for NanoString Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies Inc. and related companies with's FREE daily email newsletter.